| Product Code: ETC9976096 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Sexually Transmitted Diseases (STD) Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Sexually Transmitted Diseases (STD) Testing Market - Industry Life Cycle |
3.4 United States (US) Sexually Transmitted Diseases (STD) Testing Market - Porter's Five Forces |
3.5 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume Share, By Location of Testing, 2021 & 2031F |
4 United States (US) Sexually Transmitted Diseases (STD) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early STD testing and treatment |
4.2.2 High prevalence of STDs among the population |
4.2.3 Technological advancements in testing methods and kits |
4.3 Market Restraints |
4.3.1 Stigma associated with STD testing |
4.3.2 Lack of access to affordable testing services in certain regions |
4.3.3 Inconsistent healthcare policies and regulations |
5 United States (US) Sexually Transmitted Diseases (STD) Testing Market Trends |
6 United States (US) Sexually Transmitted Diseases (STD) Testing Market, By Types |
6.1 United States (US) Sexually Transmitted Diseases (STD) Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Chlamydia, 2021- 2031F |
6.1.4 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Syphilis, 2021- 2031F |
6.1.5 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Gonorrhea, 2021- 2031F |
6.1.6 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.1.7 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F |
6.1.8 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Human Immunodeficiency Virus, 2021- 2031F |
6.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market, By Location of Testing |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Laboratory Testing, 2021- 2031F |
6.2.3 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Point of Care (POC) Testing, 2021- 2031F |
7 United States (US) Sexually Transmitted Diseases (STD) Testing Market Import-Export Trade Statistics |
7.1 United States (US) Sexually Transmitted Diseases (STD) Testing Market Export to Major Countries |
7.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market Imports from Major Countries |
8 United States (US) Sexually Transmitted Diseases (STD) Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of STD testing centers nationwide |
8.2 Average waiting time for individuals seeking STD testing services |
8.3 Percentage of population screened for STDs annually |
8.4 Rate of follow-up treatment for positive STD cases |
8.5 Adoption rate of new STD testing technologies |
9 United States (US) Sexually Transmitted Diseases (STD) Testing Market - Opportunity Assessment |
9.1 United States (US) Sexually Transmitted Diseases (STD) Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market Opportunity Assessment, By Location of Testing, 2021 & 2031F |
10 United States (US) Sexually Transmitted Diseases (STD) Testing Market - Competitive Landscape |
10.1 United States (US) Sexually Transmitted Diseases (STD) Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Sexually Transmitted Diseases (STD) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here